The transcription factor NF-Y promotes myeloid cell survival and protects from inflammatory vascular disease
Myeloid cells orchestrate vascular inflammation through transcriptional programs that control their maturation, effector function, and survival. While lineage-determining transcription factors establish myeloid identity, our understanding of the transcriptional regulation of myeloid cell behavior in chronic inflammatory contexts remains limited. Nuclear factor-Y (NF-Y) is a trimeric CCAAT-binding transcription factor that regulates cell proliferation and differentiation and is essential for maintaining stem and progenitor cell fitness. Here, we investigate NF-Y activity in myeloid cell function and survival using integrated single-cell transcriptomics and myeloid-specific deletion of the NF-YA subunit. At RNA level, NF-Y subunit transcripts were detected across myeloid compartments, with NF-YA enriched in proliferative macrophages and immature neutrophils. In mouse atherosclerotic lesions, low NF-YA levels were associated with macrophages exhibiting lipid-handling and phagocytic signatures and with neutrophils displaying a proinflammatory phenotype. NF-Y deficiency impaired neutrophil adhesion and rolling, increased their susceptibility to apoptosis, and promoted activation and lipid accumulation in macrophages. In vivo, myeloid NF-YA deficiency reduced circulating neutrophil counts, increased macrophage and neutrophil apoptosis during acute inflammation, expanded necrotic cores, leading to larger and more unstable atherosclerotic lesions, and aggravated both atherosclerosis and injury-induced neointimal thickening. These findings identify NF-Y as a transcriptional safeguard of myeloid cell survival during inflammatory stress, thereby shaping disease progression and outcomes in vascular disease.
Authors
- Noelia A-González (ORCID: https://orcid.org/0000-0003-0533-5216)
- Carlos Silvestre-Roig (ORCID: https://orcid.org/0000-0003-1169-7475)
- Collins Osei-Sarpong (ORCID: https://orcid.org/0000-0002-1093-5147)
- Vicente Andrés (ORCID: https://orcid.org/0000-0002-0125-7209)
- Pilar Gonzalo (ORCID: https://orcid.org/0000-0001-8811-8369)
- Eva Gricar
- Mariano Malamud (ORCID: https://orcid.org/0000-0001-9754-2399)
- Merieme Farjia
- Jose Maria Gonzalez-Granado
- Lina-Marie Vöcking (ORCID: https://orcid.org/0009-0003-3323-1884)
- Raphael Chevre
- Vanesa Esteban
Institutions
- Universidad Complutense de Madrid (ES)
- University of Münster (DE)
- Spanish National Centre for Cardiovascular Research (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- University Hospital Münster (DE)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Universidad Alfonso X el Sabio (ES)
- Institute of Molecular Biology (DE)
- FH Münster University of Applied Sciences (DE)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Journal of Leukocyte Biology
- Published
- 2026-08-14
- DOI
- https://doi.org/10.1093/jleuko/qiag113
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00